Epoch Biotech

• Jinsam You

Sources: reporter.nih.gov

• National Institute on Aging

  R41, Preclinical efficacy of an APOE targeted antibody for Alzheimer's disease, R41AG092063, $499K, 2025–2027, Aug 18, 2025

Sources: reporter.nih.gov

• Longevity and cognitive resilience in a Colombian family carrying the APOE ε2 variant

  Founder, Jun 4, 2026

• REELIN-COLBOS (H3447R) in Colombian oldest-old individuals, a case series

  Founder, Dec 3, 2025

• Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevity

  Founder, Mar 1, 2025

Sources: pubmed.ncbi.nlm.nih.gov